KR980009236A - 치환된 인다닐리딘아세틸구아니딘, 이의 제조방법, 약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제 - Google Patents

치환된 인다닐리딘아세틸구아니딘, 이의 제조방법, 약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제 Download PDF

Info

Publication number
KR980009236A
KR980009236A KR1019970035527A KR19970035527A KR980009236A KR 980009236 A KR980009236 A KR 980009236A KR 1019970035527 A KR1019970035527 A KR 1019970035527A KR 19970035527 A KR19970035527 A KR 19970035527A KR 980009236 A KR980009236 A KR 980009236A
Authority
KR
South Korea
Prior art keywords
alkyl
formula
compound
alkylaryl
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019970035527A
Other languages
English (en)
Korean (ko)
Inventor
니로기 벤카타 사탸 라마크리쉬나
아룬 쿠마 제인
반지 랄
라오 벤카타 사탸 비어애브하드라 바들랴무디
아닐 바산트라오 가테
라빈드라 다타트라야 굽테
안드레아스 바이헤르트
얀-로베르트 슈바르크
Original Assignee
야코비
훽스트 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 야코비, 훽스트 아크티엔게젤샤프트 filed Critical 야코비
Publication of KR980009236A publication Critical patent/KR980009236A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C327/54—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1019970035527A 1996-07-30 1997-07-28 치환된 인다닐리딘아세틸구아니딘, 이의 제조방법, 약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제 Ceased KR980009236A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96112275.1 1996-07-30
EP96112275A EP0837055A1 (en) 1996-07-30 1996-07-30 Substituted Indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them

Publications (1)

Publication Number Publication Date
KR980009236A true KR980009236A (ko) 1998-04-30

Family

ID=8223055

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970035527A Ceased KR980009236A (ko) 1996-07-30 1997-07-28 치환된 인다닐리딘아세틸구아니딘, 이의 제조방법, 약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제

Country Status (29)

Country Link
US (1) US5900436A (https=)
EP (2) EP0837055A1 (https=)
JP (1) JP4039589B2 (https=)
KR (1) KR980009236A (https=)
CN (1) CN1064351C (https=)
AR (1) AR008095A1 (https=)
AT (1) ATE207888T1 (https=)
AU (1) AU715187B2 (https=)
BR (1) BR9704131A (https=)
CA (1) CA2211982C (https=)
CZ (1) CZ241197A3 (https=)
DE (1) DE69707777T2 (https=)
DK (1) DK0822182T3 (https=)
ES (1) ES2164283T3 (https=)
HR (1) HRP970424B1 (https=)
HU (1) HUP9701316A3 (https=)
ID (1) ID17565A (https=)
IL (1) IL121407A0 (https=)
MX (1) MX9705737A (https=)
NO (1) NO308213B1 (https=)
NZ (1) NZ328440A (https=)
PL (1) PL321392A1 (https=)
PT (1) PT822182E (https=)
RU (1) RU2176638C2 (https=)
SI (1) SI0822182T1 (https=)
SK (1) SK282128B6 (https=)
TR (1) TR199700704A2 (https=)
TW (1) TW445251B (https=)
ZA (1) ZA976735B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2384318T1 (en) 2008-12-31 2018-03-30 Ardelyx, Inc. MEASURES AND PROCEDURES FOR THE INHIBITION OF ANTIPORT INHIBITED BY NHE IN THE TREATMENT OF DISEASES RELATED TO STRENGTH OF FLAMMABILITY OR TRADEMARITY WITH SOLO, AND THE EMISSION OF GASTROINTESTINAL TREATMENT
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
GB0916163D0 (en) * 2009-09-15 2009-10-28 Shire Llc Prodrugs of guanfacine
LT2983667T (lt) 2013-04-12 2019-07-10 Ardelyx, Inc. Nhe3 rišantys junginiai ir fosfato pernešimo slopinimo būdai
CA3049678A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds useful for treating gastrointestinal tract disorders
EA201991676A1 (ru) 2017-01-09 2020-01-30 Арделикс, Инк. Ингибиторы nhe-опосредованного антипорта
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
CN116492469A (zh) * 2023-05-22 2023-07-28 遵义医科大学附属医院 一种通道阻滞剂在制备治疗和/或预防肝纤维疾病药物中的应用
CN119118881B (zh) * 2024-07-25 2026-01-02 中国农业大学 含胍基的5-氯茚满化合物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DE4421536A1 (de) * 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DK0738712T3 (da) * 1995-04-18 2000-03-06 Hoechst Ag Substituerede indenoylguanidiner med antiarytmetisk kardioprotektiv virkning

Also Published As

Publication number Publication date
AR008095A1 (es) 1999-12-09
NO308213B1 (no) 2000-08-14
TW445251B (en) 2001-07-11
ID17565A (id) 1998-01-08
CA2211982A1 (en) 1998-01-30
NZ328440A (en) 1997-11-24
NO973486L (no) 1998-02-02
AU3155497A (en) 1998-02-05
PL321392A1 (en) 1998-02-02
CN1064351C (zh) 2001-04-11
IL121407A0 (en) 1998-01-04
SK103497A3 (en) 1998-02-04
SI0822182T1 (en) 2002-04-30
HUP9701316A3 (en) 1998-07-28
DE69707777T2 (de) 2003-01-16
DE69707777D1 (de) 2001-12-06
CZ241197A3 (cs) 1998-02-18
US5900436A (en) 1999-05-04
TR199700704A2 (xx) 1998-02-21
PT822182E (pt) 2002-03-28
JPH1129545A (ja) 1999-02-02
SK282128B6 (sk) 2001-11-06
JP4039589B2 (ja) 2008-01-30
ATE207888T1 (de) 2001-11-15
HRP970424B1 (en) 2002-06-30
MX9705737A (es) 1998-02-28
CN1172104A (zh) 1998-02-04
AU715187B2 (en) 2000-01-20
HRP970424A2 (en) 1998-06-30
EP0822182A1 (en) 1998-02-04
CA2211982C (en) 2007-09-18
ZA976735B (en) 1998-01-30
RU2176638C2 (ru) 2001-12-10
HU9701316D0 (en) 1997-09-29
DK0822182T3 (da) 2002-02-25
EP0837055A1 (en) 1998-04-22
BR9704131A (pt) 1998-12-29
NO973486D0 (no) 1997-07-29
EP0822182B1 (en) 2001-10-31
ES2164283T3 (es) 2002-02-16
HUP9701316A2 (hu) 1998-03-02

Similar Documents

Publication Publication Date Title
US5591754A (en) Benzoylguanidines, pharmaceutical composition containing them and treatment of arrthythmias therewith
KR100376194B1 (ko) 퍼플로우로알킬치환된벤조일구아니딘,이의제조방법및이를함유하는약제학적조성물
KR100360127B1 (ko) 치환된1-옥소-1,2-디하이드로이소퀴놀리노일구아니딘,1,1-디옥소-2h-1,2-벤조티아지노일구아니딘및이들을함유하는약제
KR100368513B1 (ko) 퍼플루오로알킬그룹을갖는페닐-치환된알케닐카보구아니디드,이의제조방법및이를함유하는약제학적조성물
JPH07109251A (ja) オルト置換ベンゾイルグアニジン、それらの製法、医薬または診断剤としてのそれらの使用およびそれらを含有する医薬
JPH06345643A (ja) 置換ベンゾイルグアニジン、その製造方法、医薬または診断薬としてのその使用およびそれらを含有する医薬
JPH0776566A (ja) 尿素置換ベンゾイルグアニジン、その製造方法、医薬または診断剤としてのその使用およびそれを含有する医薬
JP4039589B2 (ja) 置換インダニリジンアセチルグアニジン類、それらの製造方法、医薬または診断剤としてのそれらの使用およびそれらを含有する医薬
JPH08259515A (ja) 塩基で置換されたベンゾイルグアニジン、その製造方法、医薬または診断剤としてのその使用およびそれを含有する医薬
RU2182902C2 (ru) Инденоилгуанидин, способ его получения и лекарственное средство
JPH0782234A (ja) ジアシル−置換されたグアニジン、それらの製法、医薬または診断剤としてのそれらの使用およびそれらを含有する医薬
JPH0931045A (ja) ４−フルオロアルキル−置換されたベンゾイルグアニジン、それらの製造法、医薬または診断剤としてのそれらの使用およびそれらを含有する医薬
MXPA97005737A (en) Substitute indianilidinacylukinides, procedure for its preparation, its use as medicines or diagnostic agents and medicines containing them
JPH1067731A (ja) オルト−置換されたベンゾイルグアニジン、その製法、医薬または診断剤としてのその使用およびそれを含有する医薬
JP4039587B2 (ja) 置換された１−ナフトイルグアニジン、その製法、医薬または診断剤としてのその使用およびそれを含有する医薬
KR100498799B1 (ko) 오르토-치환된벤조일구아니딘,이의제조방법및이를포함하는약제학적조성물
JPH0899950A (ja) フルオロアルキル／アルケニル置換ベンゾイルグアニジン、その調製方法、医薬または診断薬としてのその使用、それらを含有する医薬
JPH1081662A (ja) ビス−オルト−置換されたベンゾイルグアニジン、その製法、医薬または診断剤としてのその使用およびそれを含有する医薬
JPH09221465A (ja) 置換ジアリールジカルボン酸ジグアニジド、それらの製造法、薬剤または診断剤としてのそれらの使用およびそれらを含有する薬剤
JPH09169719A (ja) 置換されたベンゼンジカルボン酸ジグアニジド、それらの製法、医薬または診断剤としてのそれらの使用およびそれらを含有する医薬
JPH107644A (ja) オルト−置換されたベンゾイルグアニジン、それらの製造方法、医薬または診断薬としてのそれらの使用およびそれらを含有する医薬
DE19504805A1 (de) Basisch-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19970728

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20020723

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19970728

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20041220

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20050428

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20041220

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I